Hepperger, C. and Nachtnebel, A. (2014): Bevacizumab (Avastin®) for platinum-resistant recurrent, epithelial ovarian, fallopian tube or primary peritoneal cancer. DSD: Horizon Scanning in Oncology 48.

Hepperger, C. and Nachtnebel, A. (2011): S-1 (TeysunoTM) as first-line therapy for patients with advanced non-small cell lung cancer. DSD: Horizon Scanning in Oncology 19.